Showing results (781-790 of 1,344) with videos related to

Sort By:
Pageof 135
The Pharmacogenomics Journal|October 2, 2024
Clinical and economic outcomes of a pharmacogenomics-enriched comprehensive medication management program in a self-insured employee populationMaren S Fragala, Murray Keogh, Steven E Goldberg, et al.
The Pharmacogenomics Journal|August 1, 2024
Opioid use disorder risk alleles in self-reported assigned African American/Afro-Caribbean and European biogeographical genetic ancestry groups and in males and femalesJon E Sprague, Caroline E Freiermuth, Joshua Lambert, et al.
The Pharmacogenomics Journal|June 21, 2024
Predictive role of ITPA genetic variants in thiopurine-related myelotoxicity in Crohn's disease patientsJuliana Salazar, Pau Riera, Jordi Gordillo, et al.
The Pharmacogenomics Journal|May 3, 2006
Ethanol-responsive genes: identification of transcription factors and their role in metabolomicsR K Uddin, S M Singh
The Pharmacogenomics Journal|April 26, 2006
Pharmacogenetics of the human beta-adrenergic receptorsM R G Taylor
The Pharmacogenomics Journal|April 26, 2006
Chronic fluoxetine upregulates activity, protein and mRNA levels of cytosolic phospholipase A2 in rat frontal cortexJ S Rao, R N Ertley, H-J Lee, et al.
The Pharmacogenomics Journal|June 14, 2006
Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease)A D Roses, A M Saunders, Y Huang, et al.
The Pharmacogenomics Journal|September 6, 2006
Analysis of a missense variant of the human N-formyl peptide receptor that is associated with agonist-independent beta-arrestin association and indices of inflammationM Bhattacharya, J Wang, F M Ribeiro, et al.
The Pharmacogenomics Journal|September 20, 2006
A novel polymorphism in the 17beta-hydroxysteroid dehydrogenase type 5 (aldo-keto reductase 1C3) gene is associated with lower serum testosterone levels in caucasian menJ Jakobsson, E Palonek, M Lorentzon, et al.
The Pharmacogenomics Journal|September 20, 2006
No evidence for binding of clozapine, olanzapine and/or haloperidol to selected receptors involved in body weight regulationF M Theisen, M Haberhausen, M A Firnges, et al.
Pageof 135